{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T16:17:30Z","timestamp":1776701850955,"version":"3.51.2"},"reference-count":61,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.medmal.2009.02.008","type":"journal-article","created":{"date-parts":[[2009,4,7]],"date-time":"2009-04-07T05:05:53Z","timestamp":1239080753000},"page":"877-885","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u00c9pid\u00e9miologie des candid\u00e9mies\u00a0: \u00e9tude observationnelle prospective d\u2019un an dans l\u2019Ouest de la France"],"prefix":"10.1016","volume":"39","author":[{"given":"J.-P.","family":"Talarmin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Boutoille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Tattevin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Darg\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Weinbreck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ansart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Chennebault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Hutin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"L\u00e9autez-Nainville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gay-Andrieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Raffi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medmal.2009.02.008_bib1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1086\/520192","article-title":"Nosocomial bloodstream infections in United States hospitals: A three-year analysis","volume":"29","author":"Edmond","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/376906","article-title":"A prospective observational study of candidemia: Epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients","volume":"37","author":"Pappas","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib3","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: A persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medmal.2009.02.008_bib4","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1471-2334-6-80","article-title":"Candidaemia and antifungal therapy in a French University Hospital: Rough trends over a decade and possible links","volume":"6","author":"Sendid","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1086\/499057","article-title":"Current treatment strategies for disseminated candidiasis","volume":"42","author":"Spellberg","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib6","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/JCM.44.5.1681-1685.2006","article-title":"Epidemiology, risk factors, and prognosis of Candidaparapsilosis bloodstream infections: Case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003","volume":"44","author":"Almirante","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib7","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1128\/JCM.02122-07","article-title":"Geographic and temporal trends in isolation and antifungal susceptibility of Candidaparapsilosis: A global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/JCM.01915-07","article-title":"Candidakrusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005","volume":"46","author":"Pfaller","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib9","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1128\/JCM.42.7.3142-3146.2004","article-title":"Geographic variation in the susceptibilities of invasive isolates of Candidaglabrata to seven systemically active antifungal agents: A global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002","volume":"42","author":"Pfaller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib10","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1128\/JCM.00409-07","article-title":"Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: An 8. 5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing","volume":"45","author":"Pfaller","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib11","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2009.02.008_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1086\/380796","article-title":"Guidelines for treatment of candidiasis","volume":"38","author":"Pappas","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib13","unstructured":"SFAR, SPILF, SRLF, Soci\u00e9t\u00e9 fran\u00e7aise d\u2019h\u00e9matologie, Soci\u00e9t\u00e9 fran\u00e7aise de mycologie, Soci\u00e9t\u00e9 fran\u00e7aise de greffe de moelle. Management of invasive candidiasis and aspergillosis in adults. Rev Pneumol Clin 2004; 60 (5 Pt 1): 289\u201393."},{"key":"10.1016\/j.medmal.2009.02.008_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/jac\/dkm169","article-title":"Caspofungin for the treatment of less common forms of invasive candidiasis","volume":"60","author":"Cornely","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medmal.2009.02.008_bib15","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medmal.2009.02.008_bib16","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s10096-007-0448-4","article-title":"A first Portuguese epidemiological survey of fungaemia in a university hospital","volume":"27","author":"Costa-de-Oliveira","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib18","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10096-006-0159-2","article-title":"Attributable mortality of candidemia: A systematic review of matched cohort and case-control studies","volume":"25","author":"Falagas","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib19","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1086\/502581","article-title":"Excess mortality, hospital stay, and cost due to candidemia: A case-control study using data from population-based candidemia surveillance","volume":"26","author":"Morgan","year":"2005","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jhin.2003.08.012","article-title":"The global epidemiology of invasive Candida infections\u2013is the tide turning?","volume":"55","author":"Hobson","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.medmal.2009.02.008_bib21","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1128\/JCM.40.10.3551-3557.2002","article-title":"Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility","volume":"40","author":"Pfaller","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib22","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; Approved Standard\u20133rd Edition. 2008, CLSI doc M27-A3"},{"key":"10.1016\/j.medmal.2009.02.008_bib23","doi-asserted-by":"crossref","unstructured":"EUCAST definitive document EDef 7.1: Method for the determination of broth dilution MIC of antifungal agents for fermentative yeasts. Clin Microbiol Infect. 2008; 14: 398\u2013405.","DOI":"10.1111\/j.1469-0691.2007.01935.x"},{"key":"10.1016\/j.medmal.2009.02.008_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/clinids\/24.2.235","volume":"24","author":"Rex","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib25","doi-asserted-by":"crossref","unstructured":"EUCAST technical note on fluconazole. Clin Microbiol Infect. 2008; 14: 193\u20135.","DOI":"10.1111\/j.1469-0691.2007.01899.x"},{"key":"10.1016\/j.medmal.2009.02.008_bib26","doi-asserted-by":"crossref","first-page":"3518","DOI":"10.1128\/AAC.46.11.3518-3521.2002","article-title":"In vitro activities of 5-fluorocytosine against 8803 clinical isolates of Candida spp. : Global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods","volume":"46","author":"Pfaller","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.008_bib27","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1128\/JCM.44.3.819-826.2006","article-title":"Correlation of MIC with outcome for Candida species tested against voriconazole: Analysis and proposal for interpretive breakpoints","volume":"44","author":"Pfaller","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib28","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/AAC.43.5.1289","article-title":"Correlation between in vitro susceptibility determined by E-test and response to therapy with amphotericin B: Results from a multicenter prospective study of candidemia","volume":"43","author":"Clancy","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.008_bib29","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib30","first-page":"523","article-title":"Epidemiology of candidemia: Results of a one month French hospitals-based surveillance study in 2004","volume":"54","author":"Eloy","year":"2006","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.medmal.2009.02.008_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jinf.2007.04.003","article-title":"Trends in candidemia and antifungal susceptibility in a university hospital in Northern Ireland 2001\u20132006","volume":"55","author":"Metwally","year":"2007","journal-title":"J Infect"},{"key":"10.1016\/j.medmal.2009.02.008_bib32","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/380637","article-title":"Epidemiology of candidemia in Swiss tertiary care hospitals: Secular trends, 1991\u20132000","volume":"38","author":"Marchetti","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib33","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JCM.00773-06","article-title":"Epidemiology of candidemia in Brazil: A nationwide sentinel surveillance of candidemia in eleven medical centers","volume":"44","author":"Colombo","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib34","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1128\/JCM.40.4.1298-1302.2002","article-title":"Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study","volume":"40","author":"Diekema","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1046\/j.1469-0691.2002.00446.x","article-title":"Candidemia in French hospitals: Incidence rates and characteristics","volume":"8","author":"Richet","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medmal.2009.02.008_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0732-8893(99)00046-2","volume":"35","author":"Pfaller","year":"1999","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.diagmicrobio.2007.01.005","article-title":"Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals","volume":"58","author":"Bassetti","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2334-6-21","article-title":"Epidemiological trends in nosocomial candidemia in intensive care","volume":"6","author":"Bassetti","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib39","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1017\/S095026880400295X","article-title":"A one-year survey of candidemia in Belgium in 2002","volume":"132","author":"Swinne","year":"2004","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.medmal.2009.02.008_bib40","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s00134-007-0865-y","article-title":"Candidemia and candiduria in critically ill patients admitted to intensive care units in France: Incidence, molecular diversity, management and outcome","volume":"34","author":"Bougnoux","year":"2008","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.medmal.2009.02.008_bib41","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10096-005-1321-y","article-title":"Candida species distribution in bloodstream cultures in Lyon, France, 1998\u20132001","volume":"24","author":"Martin","year":"2005","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib42","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1128\/JCM.01840-06","article-title":"Comparative evaluation of E-test and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents","volume":"45","author":"Alexander","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib43","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1128\/JCM.41.4.1440-1446.2003","article-title":"Activities of fluconazole and voriconazole against 1586 recent clinical isolates of Candida species determined by Broth microdilution, disk diffusion, and E-test methods: Report from the ARTEMIS Global Antifungal Susceptibility Program, 2001","volume":"41","author":"Pfaller","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib44","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1128\/JCM.41.3.1087-1090.2003","article-title":"Evaluation of E-test method for determining fluconazole and voriconazole MIC for 279\u00a0clinical isolates of Candida species in frequently isolated from blood","volume":"41","author":"Maxwell","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib45","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1128\/jcm.33.3.535-540.1995","article-title":"Comparison of E-test and National Committee for Clinical Laboratory Standards broth macrodilution method for azole antifungal susceptibility testing","volume":"33","author":"Colombo","year":"1995","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib46","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1128\/JCM.40.8.2953-2958.2002","article-title":"Multicenter comparative evaluation of six commercial systems and the national committee for clinical laboratory standards m27-a broth microdilution method for fluconazole susceptibility testing of Candida species","volume":"40","author":"Morace","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib47","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1128\/JCM.39.4.1328-1333.2001","article-title":"Evaluation of E-test for direct antifungal susceptibility testing of yeasts in positive blood cultures","volume":"39","author":"Chang","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib48","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/AAC.00323-08","article-title":"In vitro susceptibilities of invasive isolates of Candida species: Rapid increase in rates of fluconazole susceptible-dose dependent Candidaglabrata isolates","volume":"52","author":"Ruan","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medmal.2009.02.008_bib49","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1128\/JCM.44.5.1740-1743.2006","article-title":"Clinical significance of azole antifungal drug cross-resistance in Candidaglabrata","volume":"44","author":"Panackal","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib50","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1128\/JCM.44.2.529-535.2006","article-title":"Triazole cross-resistance among Candida spp.: Case report, occurrence among bloodstream isolates, and implications for antifungal therapy","volume":"44","author":"Magill","year":"2006","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib51","unstructured":"Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. MMWR Recomm Rep. 2000 Oct; 49 (RR-10): 1\u2013125, CE1\u20137."},{"key":"10.1016\/j.medmal.2009.02.008_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1365-2141.2002.03414.x","article-title":"Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720\u00a0patients with haematological malignancy","volume":"117","author":"Kami","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medmal.2009.02.008_bib53","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/JCM.42.4.1519-1527.2004","article-title":"Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program","volume":"42","author":"Hajjeh","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.medmal.2009.02.008_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1007\/s15010-006-5677-4","article-title":"Comparison of risk factors for candidemia versus bacteremia in hospitalized patients","volume":"34","author":"Amrutkar","year":"2006","journal-title":"Infection"},{"key":"10.1016\/j.medmal.2009.02.008_bib55","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1086\/529435","article-title":"Factors associated with candidemia caused by non-albicans Candidaspecies versus Candidaalbicans in the intensive care unit","volume":"46","author":"Chow","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib56","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1439-0507.2007.01421.x","article-title":"Invasive fungal infections among inpatients with acquired immune deficiency syndrome at a Chinese university hospital","volume":"50","author":"Shen","year":"2007","journal-title":"Mycoses."},{"key":"10.1016\/j.medmal.2009.02.008_bib57","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1086\/520291","article-title":"Candidemia: A nosocomial complication in adults with late-stage AIDS","volume":"26","author":"Launay","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib58","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib59","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/338714","article-title":"Should vascular catheters be removed from all patients with candidemia? An evidence-based review","volume":"34","author":"Nucci","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib60","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: A propensity analysis","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medmal.2009.02.008_bib61","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1086\/378745","article-title":"Attributable mortality of nosocomial candidemia, revisited","volume":"37","author":"Gudlaugsson","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X09000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:06:28Z","timestamp":1759971988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X09000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":61,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0399077X09000614"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.008","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9pid\u00e9miologie des candid\u00e9mies\u00a0: \u00e9tude observationnelle prospective d\u2019un an dans l\u2019Ouest de la France","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2009.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}